Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
{ "Single Dose Amikacin for Uncomplicated Cystitis", "This study is looking at whether a single dose of amikacin, an antibiotic, can effectively treat uncomplicated cystitis (a bladder infection) in women seen in the emergency department. You might be eligible if you are a female emergency patient, at least 14 years old, with an uncomplicated urinary tract infection (UTI) and a positive nitrite test in your urine. The main goal is to see if your UTI symptoms improve within 3 days (72 hours) after receiving the amikacin. This study aims to show that giving a single shot of amikacin in the emergency department is a practical way to treat these UTIs, potentially saving you a trip to the pharmacy and days of taking pills.", "design": "This is an observational study planning to enroll 75 female emergency department patients with uncomplicated cystitis. You would receive a single dose of amikacin.", "commitments": "You would receive a single shot of amikacin (either into a vein or muscle) in the emergency department. The study will collect information about your age, medical history, medications, allergies, symptoms, and urinalysis results at the time of enrollment.", "compensation": "Not stated in the trial record.", "follow_up": "The study will check for resolution of your UTI symptoms at 3 days (72 hours) after treatment.", }
- Study design
- Not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Reuben Strayer, MD · PRINCIPAL_INVESTIGATOR · Maimonides Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Resolution of Urinary Tract Infection Symptoms3 days (72 hours)
\>80% of patients treated with amikacin will have resolution of urinary tract infection symptoms.